RJ

Richard Jones

Chief Executive Officer and Chairman of Management Board

Adrenomed AG

Guildford, England


Contact Information

Email
Unlock
LinkedIn

Company Information

Company
Adrenomed AG
Industry
pharmaceuticals
Employees
22.0
Seniority
C suite
Annual Revenue
9877000.0
Total Funding
53671803.0
Latest Funding
Series E

Technologies

Outlook Microsoft Office 365 Vimeo Google Maps Google Maps (Non Paid Users) Bootstrap Framework Apache WordPress.org Mobile Friendly AI

Keywords

pharmaceutical manufacturing biopharmaceutical sepsis septic shock clinical-stage precision medicine monoclonal antibody adrenomedullin vascular integrity enibarcimab fda fast track designation biomarker-guided therapy organ dysfunction mortality reduction dpp3 vascular leakage hemodynamic stability treatment efficacy phase ii trial biomarker identification critical illness adrenaline antibodies circulating dipeptidyl peptidase 3 immunotherapy acute care vascular endothelium life-threatening conditions patient heterogeneity clinical development scientific publications regulator of vascular integrity elevated levels acute heart failure tissue edema biomarker confirmation multicenter trial patient population double-blind trial randomized trial treatment effect improved outcomes hospital mortality sepsis crisis risk assessment preventive strategies knowledge translation pharmaceutical innovation pharmaceuticals medical

Get Full Contact Details

Subscribe to reveal email addresses and export contacts.

View Plans